Xenon Pharmaceuticals Inc (XENE) returns
Xenon Pharmaceuticals returns over 10 years
$1,000 invested in Xenon Pharmaceuticals ten years ago was worth $4,590 at the close on October 30, 2026, with dividends reinvested: an average return of 16.5% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +0.6% | — | $1,006 | -0.9% |
| 3 months | -41.7% | — | $582.80 | +2.1% |
| Year to date | -16.5% | — | $834.67 | +11.7% |
| 1 year | -12.3% | — | $876.73 | +12.4% |
| 3 years | +18.8% | +5.9% | $1,188 | +88.5% |
| 5 years | +20.1% | +3.7% | $1,201 | +76.0% |
| 10 years | +359.0% | +16.5% | $4,590 | +316.6% |
Xenon Pharmaceuticals return by calendar year
| Year | XENE | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -16.5% | +11.7% | -28.2% |
| 2025 | +14.3% | +17.7% | -3.4% |
| 2024 | -14.9% | +24.9% | -39.8% |
| 2023 | +16.8% | +26.2% | -9.4% |
| 2022 | +26.2% | -18.2% | +44.4% |
| 2021 | +103.1% | +28.7% | +74.4% |
| 2020 | +17.3% | +18.4% | -1.1% |
| 2019 | +107.8% | +31.2% | +76.5% |
| 2018 | +123.4% | -4.6% | +127.9% |
| 2017 | -63.3% | +21.7% | -85.0% |
| 2016 | -4.2% | +12.0% | -16.2% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: XENE financials
No forecast, no recommendation. This page describes Xenon Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.